Bracken fern carcinogenesis: Multiple intravenous doses of activated ptaquiloside induce DNA adducts, monocytosis, increased TNFα levels, and mammary gland carcinoma in rats

Biochemical and Biophysical Research Communications

Volumn 244, Issue 1, 1998, Pages 192-197

  Shahin, Mahmood ^a   Smith, Barry L ^b   Worral, Simon ^c   Moore, Michael R ^a   Seawright, Alan A ^a   Prakash, Arungundrum S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RUAKURA RESEARCH CENTRE   (New Zealand)

^c NONE

Author keywords

Adenocarcinoma; DNA adduct; Monocytosis; Ptaquiloside; TNF

Indexed keywords

PTAQUILOSIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; FEMALE; FERN; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MONOCYTE; MONOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; FILICOPHYTA; PTERIDIUM AQUILINUM;

EID: 0032489239     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8240     Document Type: Article

References (28)

1. Evans I. A., Mason J. Nature. 208:1965;913.
2. Pamucku A. M., Goksoy S. K., Price J. M. Cancer Res. 27:1976;917.
3. Jarrett W. F. H. Proc. R. Soc. Lond (Bid). 231:1987;1-11.
4. Smith B. L. Bracken Biology and Management. 1990;The Australian Institute of Agr. Sci. Wahroonga. p. 227-232.
5. Evans W. C., Patel M. C., Koohy Y. Proc. R. Soc. Edinburgh. 81:1982;29.
6. Radeleff, R. D. 1970, in, Vet. Tox. 74, 77, Lea & Febiger, Philadelphia.
7. Watson W. A., Barlow R. M., Barnett K. C. Vet. Rec. 77:1965;1060.
8. Pamucku A. M., Price J. M. J. Natl. Cancer Inst. 43:1969;275-281.
9. Hirono I., Aiso S., Hosaka S., Yamaji T., Haga M. Carcinogenesis. 4:1983;885-887.
10. Ojika M., Wakamatsu K., Niwa H., Yamada K. Tetrahedron. 43:1987;5261.
11. Hirono I., Yamada K., Niwa H., Shizuri Y., Ojika M., Hosaka S., Yamaji T., Wakamatsu K., Kigoshi H., Niiyama K., Yousaki Y. Cancer Lett. 21:1984;239-246.
12. Hirono I., Ognio H., Fujimoto M., Yamada K., Yoshida Y., Ikagawa M., Okumura M. J. Natl. Cancer Inst. 79:1987;1143-1149.
13. Smith B. L., Shaw G., Prakash A. S., Seawright A. A. Colgate S. M., Dorling P. R. Plant Associated Toxins. 1994;31-172 CAB International, Wallingford.
14. Prakash A. S., Pereira T., Smith B. L., Shaw G., Seawright A. A. Nat. Toxin. 4:1996;221-227.
15. Oelrichs P. B., NG J., Bartely J. Phytochemistry. 40:1995;53-56.
16. Brunborg G., Soderlund E. J., Holme J. A., Dybing E. Chem. Biol. Interact. 101:1996;33-48.
17. Hogan M. M. Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevanch E. M., Stober W. Current Protocols in Immunology. 1991;6.10.1-6.10.5 Greene Publishing and Wiley-Interscience, New York.
18. Moore D. D. Current Protocols in Molecular Biology. 1994;Wiley, New York. p. 2.2.1.
19. Shahin M., Smith B. L., Moore M. C., Seawright A. A., Prakash A. S. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 2:1996;21.
20. Shahin M., Smith B. L., Moore M. R., Prakash A. S. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 3:1995;174.21.
21. Hirono I., Aiso S., Yamaji T., Mori H., Yamada K., Niwa H., Ojika M., Wukamatsu K., Kigoshi H., Niiymama K., Uosaki Y. Gann. 75:1984;833.
22. Russo J., Wilgus G., Russo I. H. Am. J. Pathol. 96:1979;721-734.
23. Cameron D. J. J. Reticuloendothelial Soc. 32:1982;247-256.
24. Adams D. O., Nathan C. F. Immun. Today. 4:1983;166-170.
25. Brouckaret P. G. G., Leroux-Roach G. L., Guisez Y., Tavernier J., Fiers W. Int. J. Cancer. 38:1986;763-769.
26. Balkwill F. R., Lee A., Aldam G. Cancer Res. 96:1986;3990-3993.
27. Fidler, I. J. Raz, A. 1981, Lymphokines, Pick, E. 3, 345, 363, Academic Press, New York.
28. Hibbs J. J. Jr. J. Natl. Cancer Inst. 53:1974;1287-1492.